In lung cancer and gastric cancer, miR-1269a can also promote tumor cell proliferation and cell cycle progression and inhibit tumor cell apoptosis by activating the PI3K/AKT signaling pathway and inhibiting the caspase-9-mediated apoptotic pathway, respectively. This evidence concerns the gene AKT1 and lung carcinoma.